-
1
-
-
18444374462
-
Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure
-
Baicu CF, Zile MR, Aurigemma GP, Gaasch WH. Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation (2005); 111: 2306-2312.
-
(2005)
Circulation
, vol.111
, pp. 2306-2312
-
-
Baicu, C.F.1
Zile, M.R.2
Aurigemma, G.P.3
Gaasch, W.H.4
-
2
-
-
28244454592
-
Physiological determinants of the variation in left ventricular hypertrophy from early adolescence to late adulthood in healthy subjects
-
Cain PA, Ahl R, Hedstrom E, Ugander M, Allansdotter-Johnsson A, Friberg P, Marild S, Arheden H. Physiological determinants of the variation in left ventricular hypertrophy from early adolescence to late adulthood in healthy subjects. Clin Physiol Funct Imaging (2005); 25: 1-8.
-
(2005)
Clin Physiol Funct Imaging
, vol.25
, pp. 1-8
-
-
Cain, P.A.1
Ahl, R.2
Hedstrom, E.3
Ugander, M.4
Allansdotter-Johnsson, A.5
Friberg, P.6
Marild, S.7
Arheden, H.8
-
3
-
-
0038460302
-
The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The jnc 7 report
-
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The jnc 7 report. JAMA (2003); 289: 2560-2572.
-
(2003)
JAMA
, vol.289
, pp. 2560-2572
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
Cushman, W.C.4
Green, L.A.5
Izzo Jr., J.L.6
Jones, D.W.7
Materson, B.J.8
Oparil, S.9
Wright, J.T.10
Roccella, E.J.11
-
4
-
-
0035818884
-
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
-
Valsartan for the Heart Failure Trial Investigators
-
Cohn JN, Tognoni G, Valsartan for the Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. New Engl J Med (2001); 345: 1667-1675.
-
(2001)
New Engl J Med
, vol.345
, pp. 1667-1675
-
-
Cohn, J.N.1
Tognoni, G.2
-
5
-
-
0037160968
-
Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
LIFE Study Group
-
Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet (2002); 359: 995-1003.
-
(2002)
Lancet
, vol.359
, pp. 995-1003
-
-
Dahlof, B.1
Devereux, R.B.2
Kjeldsen, S.E.3
Julius, S.4
Beevers, G.5
de Faire, U.6
Fyhrquist, F.7
Ibsen, H.8
Kristiansson, K.9
Lederballe-Pedersen, O.10
Lindholm, L.H.11
Nieminen, M.S.12
Omvik, P.13
Oparil, S.14
Wedel, H.15
-
6
-
-
33750125886
-
Validation of 2D strain: A comparison with sonomicrometry and conventional strain imaging
-
(Abstract Supplement)
-
Donal E, Thibault H, Bergerot C, Loufouat J, Ovize M, Derumeaux GA. Validation of 2D strain: A comparison with sonomicrometry and conventional strain imaging (Abstr). Eur Heart J (2005); 26 (Abstract Supplement): 105.
-
(2005)
Eur Heart J
, vol.26
, pp. 105
-
-
Donal, E.1
Thibault, H.2
Bergerot, C.3
Loufouat, J.4
Ovize, M.5
Derumeaux, G.A.6
-
7
-
-
0037366545
-
Feasibility and reproducibility of off-line tissue Doppler measurement of regional myocardial function during dobutamine stress echocardiography
-
MYDISE Investigators
-
Fraser AG, Payne N, Madler CF, Janerot-Sjoberg B, Lind B, Grocott-Mason RM, Ionescu AA, Florescu N, Wilkenshoff U, Lancellotti P, Wutte M, Brodin LA, MYDISE Investigators. Feasibility and reproducibility of off-line tissue Doppler measurement of regional myocardial function during dobutamine stress echocardiography. Eur J Echocardiogr (2003); 4: 43-53.
-
(2003)
Eur J Echocardiogr
, vol.4
, pp. 43-53
-
-
Fraser, A.G.1
Payne, N.2
Madler, C.F.3
Janerot-Sjoberg, B.4
Lind, B.5
Grocott-Mason, R.M.6
Ionescu, A.A.7
Florescu, N.8
Wilkenshoff, U.9
Lancellotti, P.10
Wutte, M.11
Brodin, L.A.12
-
8
-
-
0028877694
-
Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function
-
Gottdiener JS, Livengood SV, Meyer PS, Chase GA. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. J Am Coll Cardiol (1995); 25: 424-430.
-
(1995)
J Am Coll Cardiol
, vol.25
, pp. 424-430
-
-
Gottdiener, J.S.1
Livengood, S.V.2
Meyer, P.S.3
Chase, G.A.4
-
9
-
-
33644499451
-
Differing myocardial response to a single session of hemodialysis in end-stage renal disease with and without type 2 diabetes mellitus and coronary artery disease
-
(February 2, 2006)
-
Govind SC, Roumina S, Brodin LÅ, Nowak J, Ramesh SS, Saha SK. Differing myocardial response to a single session of hemodialysis in end-stage renal disease with and without type 2 diabetes mellitus and coronary artery disease. Cardiovasc Ultrasound (2006); 4: 9 (February 2, 2006).
-
(2006)
Cardiovasc Ultrasound
, vol.4
, pp. 9
-
-
Govind, S.C.1
Roumina, S.2
Brodin, L.Å.3
Nowak, J.4
Ramesh, S.S.5
Saha, S.K.6
-
10
-
-
3042771034
-
Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in dog and rat models of in vivo reperfused myocardial infarction
-
Jugdutt BI, Menon V. Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in dog and rat models of in vivo reperfused myocardial infarction. J Card Fail (2004); 10: 74-82.
-
(2004)
J Card Fail
, vol.10
, pp. 74-82
-
-
Jugdutt, B.I.1
Menon, V.2
-
11
-
-
2942635317
-
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial
-
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A, VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial. Lancet (2004); 363: 2022-2031.
-
(2004)
Lancet
, vol.363
, pp. 2022-2031
-
-
Julius, S.1
Kjeldsen, S.E.2
Weber, M.3
Brunner, H.R.4
Ekman, S.5
Hansson, L.6
Hua, T.7
Laragh, J.8
McInnes, G.T.9
Mitchell, L.10
Plat, F.11
Schork, A.12
Smith, B.13
Zanchetti, A.14
-
12
-
-
0347988111
-
Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system
-
(Review)
-
Levi BI. Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system (Review). Circulation (2004); 109: 8-13.
-
(2004)
Circulation
, vol.109
, pp. 8-13
-
-
Levi, B.I.1
-
13
-
-
3242672555
-
Left ventricular isovolumic velocity and duration variables calculated from colour-coded myocardial velocity images in normal individuals
-
Lind B, Nowak J, Cain P, Quintana M, Brodin LA. Left ventricular isovolumic velocity and duration variables calculated from colour-coded myocardial velocity images in normal individuals. Eur J Echocardiogr (2004); 5: 284-293.
-
(2004)
Eur J Echocardiogr
, vol.5
, pp. 284-293
-
-
Lind, B.1
Nowak, J.2
Cain, P.3
Quintana, M.4
Brodin, L.A.5
-
14
-
-
33645394575
-
Measurement of strain and strain rate by echocardiography: Ready for prime time
-
Marwick TH. Measurement of strain and strain rate by echocardiography: ready for prime time ? J Am Coll Cardiol (2006); 47: 1313-1327.
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 1313-1327
-
-
Marwick, T.H.1
-
15
-
-
0032799557
-
Correlation between changes in morphology, electrical properties, and angiotensin-converting enzyme activity in the failing heart
-
de Mello WC, Crespo MJ. Correlation between changes in morphology, electrical properties, and angiotensin-converting enzyme activity in the failing heart. Eur J Pharmacol (1999); 378: 187-194.
-
(1999)
Eur J Pharmacol
, vol.378
, pp. 187-194
-
-
de Mello, W.C.1
Crespo, M.J.2
-
16
-
-
0037112321
-
Crumbling of left ventricular hypertrophy as a surrogate end point
-
[the losartan for intervention for endpoint reduction in hypertension (life) study editorial]
-
Messerli FH, Mehra MR. Crumbling of left ventricular hypertrophy as a surrogate end point [the losartan for intervention for endpoint reduction in hypertension (life) study editorial]. Am J Cardiol (2002); 90: 1133-1134.
-
(2002)
Am J Cardiol
, vol.90
, pp. 1133-1134
-
-
Messerli, F.H.1
Mehra, M.R.2
-
17
-
-
0030959747
-
Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension
-
Palka P, Lange A, Fleming AD, Donnelly JE, Dutka DP, Starkey IR, Shaw TR, Sutherland GR, Fox KA. Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension. J Am Coll Cardiol (1997); 30: 760-768.
-
(1997)
J Am Coll Cardiol
, vol.30
, pp. 760-768
-
-
Palka, P.1
Lange, A.2
Fleming, A.D.3
Donnelly, J.E.4
Dutka, D.P.5
Starkey, I.R.6
Shaw, T.R.7
Sutherland, G.R.8
Fox, K.A.9
-
18
-
-
0242490542
-
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
-
Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM, Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med (2003); 349: 1893-1906.
-
(2003)
N Engl J Med
, vol.349
, pp. 1893-1906
-
-
Pfeffer, M.A.1
McMurray, J.J.2
Velazquez, E.J.3
Rouleau, J.L.4
Kober, L.5
Maggioni, A.P.6
Solomon, S.D.7
Swedberg, K.8
Van de Werf, F.9
White, H.10
Leimberger, J.D.11
Henis, M.12
Edwards, S.13
Zelenkofske, S.14
Sellers, M.A.15
Califf, R.M.16
-
19
-
-
0034636189
-
Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease
-
Querejeta R, Varo N, Lopez B, Larman M, Artinano E, Etayo JC, Martinez Ubago JL, Gutierrez-Stampa M, Emparanza JI, Gil MJ, Monreal I, Mindan JP, Diez J. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation (2000); 101: 1729-1735.
-
(2000)
Circulation
, vol.101
, pp. 1729-1735
-
-
Querejeta, R.1
Varo, N.2
Lopez, B.3
Larman, M.4
Artinano, E.5
Etayo, J.C.6
Martinez Ubago, J.L.7
Gutierrez-Stampa, M.8
Emparanza, J.I.9
Gil, M.J.10
Monreal, I.11
Mindan, J.P.12
Diez, J.13
-
20
-
-
5544261224
-
Myocardial velocities measured during adenosine, dobutamine and supine bicycle exercise: A tissue Doppler study in healthy volunteers
-
Saha SK, Brodin LA, Lind B, Svedenhag J, Straat E, Gunnes S. Myocardial velocities measured during adenosine, dobutamine and supine bicycle exercise: A tissue Doppler study in healthy volunteers. Clin Physiol Funct Imaging (2004); 24: 281-288.
-
(2004)
Clin Physiol Funct Imaging
, vol.24
, pp. 281-288
-
-
Saha, S.K.1
Brodin, L.A.2
Lind, B.3
Svedenhag, J.4
Straat, E.5
Gunnes, S.6
-
21
-
-
0033968703
-
Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study)
-
Wachtell K, Smith G, Gerdts E, Dahlof B, Nieminen MS, Papademetriou V, Bella JN, Ibsen H, Rokkedal J, Devereux RB. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Am J Cardiol (2000); 85: 466-472.
-
(2000)
Am J Cardiol
, vol.85
, pp. 466-472
-
-
Wachtell, K.1
Smith, G.2
Gerdts, E.3
Dahlof, B.4
Nieminen, M.S.5
Papademetriou, V.6
Bella, J.N.7
Ibsen, H.8
Rokkedal, J.9
Devereux, R.B.10
-
22
-
-
2942695964
-
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE trial
-
Weber MA, Julius S, Kjeldsen SE, Brunner HR, Ekman S, Hansson L, Hua T, Laragh JH, McInnes GT, Mitchell L, Plat F, Schork MA, Smith B, Zanchetti A. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE trial. Lancet (2004); 363: 2049-2051.
-
(2004)
Lancet
, vol.363
, pp. 2049-2051
-
-
Weber, M.A.1
Julius, S.2
Kjeldsen, S.E.3
Brunner, H.R.4
Ekman, S.5
Hansson, L.6
Hua, T.7
Laragh, J.H.8
McInnes, G.T.9
Mitchell, L.10
Plat, F.11
Schork, M.A.12
Smith, B.13
Zanchetti, A.14
-
23
-
-
0036073312
-
Myocardial function defined by strain rate and strain during alterations in inotropic states and heart rate
-
Weidemann F, Jamal F, Sutherland GR, Claus P, Kowalski M, Hatle L, Scheerder ID, Bijnens B, Rademakers FE. Myocardial function defined by strain rate and strain during alterations in inotropic states and heart rate. Am J Physiol Heart Circ Physiol (2002); 283: H792-H799.
-
(2002)
Am J Physiol Heart Circ Physiol
, vol.283
-
-
Weidemann, F.1
Jamal, F.2
Sutherland, G.R.3
Claus, P.4
Kowalski, M.5
Hatle, L.6
Scheerder, I.D.7
Bijnens, B.8
Rademakers, F.E.9
|